Nine cases (7.2%) show more than one molecular feature (so-called “multiple classifier” tumors): 2 tumors are POLE-p53abn, 1 tumor is POLE-MMRd, 1 tumor is POLE-MMRd-p53abn, 5 tumors are MMRd-p53abn. The gene discussed is POLE; the disease is neoplasm.